(6-055) Dose Response in Hematologic Malignancy Patients Receiving Romiplostim for Thrombocytopenia

Tuesday, December 6, 2022

10:45 AM – 11:45 AM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Oncology/Hematology

Co-Author(s): Belyin Gutierrez Euceda, Elizabeth Rogers, Meredith Moorman

Primary Author(s)

Haneen K. Ottallah
Pharmacy Student
University of North Carolina Eshelman School of Pharmacy, North Carolina